Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
BMC Complement Med Ther ; 20(1): 73, 2020 Mar 06.
Artículo en Inglés | MEDLINE | ID: mdl-32143619

RESUMEN

BACKGROUND: Recent studies indicated that seeded fibril formation and toxicity of α-synuclein (α-syn) play a main role in the pathogenesis of certain diseases including Parkinson's disease (PD), multiple system atrophy, and dementia with Lewy bodies. Therefore, examination of compounds that abolish the process of seeding is considered a key step towards therapy of several synucleinopathies. METHODS: Using biophysical, biochemical and cell-culture-based assays, assessment of eleven compounds, extracted from Chinese medicinal herbs, was performed in this study for their effect on α-syn fibril formation and toxicity caused by the seeding process. RESULTS: Salvianolic acid B and dihydromyricetin were the two compounds that strongly inhibited the fibril growth and neurotoxicity of α-syn. In an in-vitro cell model, these compounds decreased the insoluble phosphorylated α-syn and aggregation. Also, in primary neuronal cells, these compounds showed a reduction in α-syn aggregates. Both compounds inhibited the seeded fibril growth with dihydromyricetin having the ability to disaggregate preformed α-syn fibrils. In order to investigate the inhibitory mechanisms of these two compounds towards fibril formation, we demonstrated that salvianolic acid B binds predominantly to monomers, while dihydromyricetin binds to oligomeric species and to a lower extent to monomers. Remarkably, these two compounds stabilized the soluble non-toxic oligomers lacking ß-sheet content after subjecting them to proteinase K digestion. CONCLUSIONS: Eleven compounds were tested but only two showed inhibition of α-syn aggregation, seeded fibril formation and toxicity in vitro. These findings highlight an essential beginning for development of new molecules in the field of synucleinopathies treatment.


Asunto(s)
Medicamentos Herbarios Chinos/farmacología , Medicamentos Herbarios Chinos/toxicidad , Extractos Vegetales/farmacología , Extractos Vegetales/toxicidad , alfa-Sinucleína/antagonistas & inhibidores , Animales , Benzofuranos/farmacología , Benzofuranos/toxicidad , Flavonoles/farmacología , Flavonoles/toxicidad , Células HEK293 , Humanos , Ratones , Estructura Molecular , Agregación Patológica de Proteínas , Sinucleinopatías/tratamiento farmacológico
2.
Int J Radiat Biol ; 91(3): 286-93, 2015 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-25488006

RESUMEN

PURPOSE: To examine the impact of electromagnetic radiation, produced by GSM (Global System for Mobile communications) mobile phones, Wi-Fi (Wireless-Fidelity) routers and wireless DECT (Digital Enhanced Cordless Telecommunications) phones, on the nematode Caenorhabditis elegans. MATERIALS AND METHODS: We exposed synchronized populations, of different developmental stages, to these wireless devices at E-field levels below ICNIRP's (International Commission on Non-Ionizing Radiation Protection) guidelines for various lengths of time. WT (wild-type) and aging- or stress-sensitive mutant worms were examined for changes in growth, fertility, lifespan, chemotaxis, short-term memory, increased ROS (Reactive Oxygen Species) production and apoptosis by using fluorescent marker genes or qRT-PCR (quantitative Reverse Transcription-Polymerase Chain Reaction). RESULTS: No statistically significant differences were found between the exposed and the sham/control animals in any of the experiments concerning lifespan, fertility, growth, memory, ROS, apoptosis or gene expression. CONCLUSIONS: The worm appears to be robust to this form of (pulsed) radiation, at least under the exposure conditions used.


Asunto(s)
Caenorhabditis elegans/efectos de la radiación , Teléfono Celular , Campos Electromagnéticos/efectos adversos , Animales , Animales Modificados Genéticamente , Apoptosis/efectos de la radiación , Caenorhabditis elegans/crecimiento & desarrollo , Caenorhabditis elegans/fisiología , Quimiotaxis/efectos de la radiación , Femenino , Fertilidad/efectos de la radiación , Expresión Génica/efectos de la radiación , Genes de Helminto/efectos de la radiación , Crecimiento/efectos de la radiación , Longevidad/efectos de la radiación , Masculino , Memoria a Corto Plazo/efectos de la radiación , Degeneración Nerviosa/etiología , Radiobiología , Especies Reactivas de Oxígeno/metabolismo , Tecnología Inalámbrica
3.
J Neurochem ; 90(6): 1511-20, 2004 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-15341534

RESUMEN

Proteasomal dysfunction may play a role in a number of neurodegenerative conditions, and in particular Parkinson's disease (PD) and related Lewy body (LB) diseases. Application of proteasomal inhibitors to neuronal cell culture systems is associated with survival-promoting effects or with cell death depending on the model system. We have applied pharmacological proteasomal inhibitors to cultured neonatal mouse sympathetic neurons in order to investigate whether these catecholaminergic neurons, which are affected in PD, are sensitive to proteasomal inhibition and, if so, which cell death pathway is activated. We report here that proteasomal inhibition leads to apoptotic death of mouse sympathetic neurons. This death is accompanied by caspase 3 activation and cytochrome c release from the mitochondria and is abrogated by caspase inhibition. Bax deletion prevented both cytochrome c release and caspase 3 activation, and also provided complete protection against proteasomal inhibition-induced death. Bcl-2 overexpression achieved a similar survival-promoting effect. There was no change in Bax levels following proteasomal inhibition, suggesting that Bax itself is not regulated by the proteasome in this cell culture system, and that a primary increase in Bax is unlikely to account for death. In contrast, levels of the BH3-only protein, Bim, increased with proteasomal inhibition. We conclude that proteasomal inhibition of mouse sympathetic neurons activates the intrinsic apoptotic pathway involving bcl-2 family members and the mitochondria.


Asunto(s)
Acetilcisteína/análogos & derivados , Acetilcisteína/farmacología , Apoptosis/efectos de los fármacos , Ganglios Simpáticos/citología , Complejos Multienzimáticos/antagonistas & inhibidores , Neuronas/efectos de los fármacos , Oligopéptidos/farmacología , Proteínas Proto-Oncogénicas c-bcl-2 , Transducción de Señal/efectos de los fármacos , Animales , Animales Recién Nacidos , Proteínas Reguladoras de la Apoptosis , Proteína 11 Similar a Bcl2 , Western Blotting/métodos , Proteínas Portadoras/metabolismo , Caspasa 3 , Caspasas/metabolismo , Supervivencia Celular/efectos de los fármacos , Células Cultivadas , Cisteína Endopeptidasas , Inhibidores de Cisteína Proteinasa/farmacología , Citocromos c/metabolismo , Relación Dosis-Respuesta a Droga , Interacciones Farmacológicas , Inhibidores Enzimáticos/farmacología , Genes bcl-2/fisiología , Proteínas Fluorescentes Verdes , Inmunohistoquímica/métodos , Proteínas Luminiscentes/metabolismo , Proteínas de la Membrana/metabolismo , Ratones , Ratones Noqueados , Neuronas/citología , Complejo de la Endopetidasa Proteasomal , Proteínas Proto-Oncogénicas/metabolismo , Rodaminas/metabolismo , Factores de Tiempo , Ubiquitina/metabolismo , Proteína X Asociada a bcl-2
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA